PL3856213T3 - Sposoby leczenia zakażenia z zastosowaniem bakterii - Google Patents

Sposoby leczenia zakażenia z zastosowaniem bakterii

Info

Publication number
PL3856213T3
PL3856213T3 PL19866580.4T PL19866580T PL3856213T3 PL 3856213 T3 PL3856213 T3 PL 3856213T3 PL 19866580 T PL19866580 T PL 19866580T PL 3856213 T3 PL3856213 T3 PL 3856213T3
Authority
PL
Poland
Prior art keywords
infections
bacteria
treatment
methods
Prior art date
Application number
PL19866580.4T
Other languages
English (en)
Inventor
Michael J. Newman
Original Assignee
Indaptus Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indaptus Therapeutics, Inc. filed Critical Indaptus Therapeutics, Inc.
Publication of PL3856213T3 publication Critical patent/PL3856213T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL19866580.4T 2018-09-27 2019-09-26 Sposoby leczenia zakażenia z zastosowaniem bakterii PL3856213T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862737762P 2018-09-27 2018-09-27
PCT/US2019/053289 WO2020069211A1 (en) 2018-09-27 2019-09-26 Methods of treatment of infections using bacteria

Publications (1)

Publication Number Publication Date
PL3856213T3 true PL3856213T3 (pl) 2024-07-08

Family

ID=69947978

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19866580.4T PL3856213T3 (pl) 2018-09-27 2019-09-26 Sposoby leczenia zakażenia z zastosowaniem bakterii

Country Status (16)

Country Link
US (2) US11147844B2 (pl)
EP (1) EP3856213B1 (pl)
JP (1) JP7570321B2 (pl)
KR (1) KR102891707B1 (pl)
CN (1) CN112770764B (pl)
AU (2) AU2019347502A1 (pl)
BR (1) BR112021005762A2 (pl)
DK (1) DK3856213T3 (pl)
EA (1) EA202190546A1 (pl)
ES (1) ES2980646T3 (pl)
FI (1) FI3856213T3 (pl)
IL (1) IL281775B2 (pl)
MX (1) MX2021003551A (pl)
PL (1) PL3856213T3 (pl)
PT (1) PT3856213T (pl)
WO (1) WO2020069211A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3856213T3 (da) * 2018-09-27 2024-05-27 Indaptus Therapeutics Inc Fremgangsmåder til behandling af infektioner under anvendelse af bakterier
CN113045498B (zh) * 2021-03-24 2023-01-24 江苏食品药品职业技术学院 一种1,5-二芳基吡唑衍生物、合成方法及用途
CN114717178A (zh) * 2022-03-03 2022-07-08 中国医学科学院医学生物学研究所 一种树鼩睾丸间质细胞的分离培养方法及其应用
KR20250106293A (ko) * 2022-11-17 2025-07-09 인댑투스 테라퓨틱스, 인크. 사멸된 온전한 박테리아를 이용한 암 및 감염성 질환의 치료

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5997881A (en) 1995-11-22 1999-12-07 University Of Maryland, Baltimore Method of making non-pyrogenic lipopolysaccharide or A
FR2822071B1 (fr) 2001-03-15 2005-07-01 Pf Medicament Utilisation d'une fraction membranaire de bacteries a gram negatif pour induire la maturation des cellules dendritiques
ITRM20030394A1 (it) 2003-08-12 2005-02-13 Maria Gabriella Santoro Uso dell'indometacina e derivati come farmaci antivirali e relative composizioni farmaceutiche.
EA030573B1 (ru) 2013-01-02 2018-08-31 Дикой Байосистемз, Инк. Композиции и способы для лечения рака с применением бактерий
HUE052575T2 (hu) 2014-12-18 2021-05-28 Helperby Therapeutics Ltd Új kombináció és alkalmazás
US20200056145A1 (en) * 2017-04-17 2020-02-20 The Regents Of The University Of California Engineered commensal bacteria and methods of use
CN107184613A (zh) * 2017-05-23 2017-09-22 山东大学 一种促进乙型肝炎病毒清除的益生菌组合物及其应用
DK3856213T3 (da) * 2018-09-27 2024-05-27 Indaptus Therapeutics Inc Fremgangsmåder til behandling af infektioner under anvendelse af bakterier

Also Published As

Publication number Publication date
FI3856213T3 (fi) 2024-05-30
DK3856213T3 (da) 2024-05-27
EP3856213A4 (en) 2022-07-06
WO2020069211A1 (en) 2020-04-02
KR102891707B1 (ko) 2025-11-27
EA202190546A1 (ru) 2021-09-10
US11147844B2 (en) 2021-10-19
EP3856213B1 (en) 2024-03-06
CN112770764B (zh) 2024-12-03
JP7570321B2 (ja) 2024-10-21
US20200101119A1 (en) 2020-04-02
MX2021003551A (es) 2021-08-16
AU2019347502A1 (en) 2021-04-22
US12383585B2 (en) 2025-08-12
EP3856213A1 (en) 2021-08-04
IL281775B2 (en) 2025-05-01
PT3856213T (pt) 2024-06-03
AU2026203814A1 (en) 2026-06-04
KR20210068462A (ko) 2021-06-09
BR112021005762A2 (pt) 2021-06-29
CA3114110A1 (en) 2020-04-02
ES2980646T3 (es) 2024-10-02
IL281775A (en) 2021-05-31
IL281775B1 (en) 2025-01-01
US20220031768A1 (en) 2022-02-03
JP2022502439A (ja) 2022-01-11
CN112770764A (zh) 2021-05-07

Similar Documents

Publication Publication Date Title
ZA202002069B (en) Novel mek-inhibitor for the treatment of viral and bacterial infections
ZA201703245B (en) Combination therapy for treatment of resistant bacterial infections
GB201804514D0 (en) Treatment of pyroptosis
SG11202104222TA (en) Method of treatment of biological surfaces
PT3565551T (pt) Métodos de tratamento de infeções bacterianas com uma combinação de vaborbactam e meropenem
IL281775A (en) Methods of treatment of infections using bacteria
DK3630111T3 (en) Compounds and methods for treating bacterial infections
IL290915A (en) Bacterial buginosis treatment
IL290983A (en) Treatment methods
EP3285787B8 (en) Treatment of bacterial infections in aquaculture
GB201804515D0 (en) Treatment of necroptosis
SG11202003009QA (en) Methods of treating bacterial infections
GB201918853D0 (en) Methods of treatment
SI3781172T1 (sl) Zdravljenje pljučnice
EP3448377A4 (en) METHODS FOR THE TREATMENT OF AN INFECTION
HK40036490A (en) Methods of treating bacterial infections
GB201801249D0 (en) Methods of treatment
GB201820236D0 (en) Method of treatment
GB201820157D0 (en) Method of treatment
GB201900942D0 (en) Methods of treatment
HK40062182A (en) Method of treatment
GB201806569D0 (en) Method of treatment
GB201804021D0 (en) Method of treatment
GB201619704D0 (en) Treatment of pathogenic infections